-
1
-
-
24644439190
-
Trends in the leading causes of death in the United States, 1970-2002
-
Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970-2002. JAMA 2005;294:1255-9.
-
(2005)
JAMA
, vol.294
, pp. 1255-1259
-
-
Jemal, A.1
Ward, E.2
Hao, Y.3
Thun, M.4
-
2
-
-
33745083936
-
The emerging roles of DNA methylation in the clinical management of prostate cancer
-
Perry AS, Foley R, Woodson K, Lawler M. The emerging roles of DNA methylation in the clinical management of prostate cancer. Endocr Relat Cancer 2006; 13:357-77.
-
(2006)
Endocr Relat Cancer
, vol.13
, pp. 357-377
-
-
Perry, A.S.1
Foley, R.2
Woodson, K.3
Lawler, M.4
-
3
-
-
0036184623
-
Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features
-
Maruyama R, Toyooka S, Toyooka KO, et al. Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features. Clin Cancer Res 2002;8:514-9.
-
(2002)
Clin Cancer Res
, vol.8
, pp. 514-519
-
-
Maruyama, R.1
Toyooka, S.2
Toyooka, K.O.3
-
4
-
-
0037068312
-
CpG island hypermethylation and tumor suppressor genes: A booming present, a brighter future
-
Esteller M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 2002;21:5427-40.
-
(2002)
Oncogene
, vol.21
, pp. 5427-5440
-
-
Esteller, M.1
-
5
-
-
19944429845
-
A quantitative promoter methylation profile of prostate cancer
-
Jeronimo C, Henrique R, Hoque MO, et al. A quantitative promoter methylation profile of prostate cancer. Clin Cancer Res 2004;10:8472-8.
-
(2004)
Clin Cancer Res
, vol.10
, pp. 8472-8478
-
-
Jeronimo, C.1
Henrique, R.2
Hoque, M.O.3
-
6
-
-
0036515416
-
Emerging molecular markers of cancer
-
Sidransky D. Emerging molecular markers of cancer. Nat Rev Cancer 2002;2:210-9.
-
(2002)
Nat Rev Cancer
, vol.2
, pp. 210-219
-
-
Sidransky, D.1
-
7
-
-
18144411303
-
Role of the Ras-association domain family 1 tumor suppressor gene in human cancers
-
Agathanggelou A, Cooper WN, Latif F. Role of the Ras-association domain family 1 tumor suppressor gene in human cancers. Cancer Res 2005; 65:3497-508.
-
(2005)
Cancer Res
, vol.65
, pp. 3497-3508
-
-
Agathanggelou, A.1
Cooper, W.N.2
Latif, F.3
-
8
-
-
21544483241
-
Methylation of the tumor suppressor gene RASSF1A in human tumors
-
Pfeifer GP, Dammann R. Methylation of the tumor suppressor gene RASSF1A in human tumors. Biochemistry (Mosc) 2005;70:576-83.
-
(2005)
Biochemistry (Mosc)
, vol.70
, pp. 576-583
-
-
Pfeifer, G.P.1
Dammann, R.2
-
9
-
-
27944477357
-
Epigenetic alterations in neuroendocrine tumors: Methylation of RAS-association domain family 1, isoform A and p16 genes are associated with metastasis
-
Liu L, Broaddus RR, Yao JC, et al. Epigenetic alterations in neuroendocrine tumors: methylation of RAS-association domain family 1, isoform A and p16 genes are associated with metastasis. Mod Pathol 2005;18: 1632-40.
-
(2005)
Mod Pathol
, vol.18
, pp. 1632-1640
-
-
Liu, L.1
Broaddus, R.R.2
Yao, J.C.3
-
10
-
-
0035795676
-
Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression
-
Burbee DG, Forgacs E, Zochbauer-Muller S, et al. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst 2001;93:691-9.
-
(2001)
J Natl Cancer Inst
, vol.93
, pp. 691-699
-
-
Burbee, D.G.1
Forgacs, E.2
Zochbauer-Muller, S.3
-
11
-
-
0033918563
-
Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3
-
Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 2000;25:315-9.
-
(2000)
Nat Genet
, vol.25
, pp. 315-319
-
-
Dammann, R.1
Li, C.2
Yoon, J.H.3
Chin, P.L.4
Bates, S.5
Pfeifer, G.P.6
-
12
-
-
0035932393
-
Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours
-
Agathanggelou A, Honorio S, Macartney DP, et al. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours. Oncogene 2001;20:1509-18.
-
(2001)
Oncogene
, vol.20
, pp. 1509-1518
-
-
Agathanggelou, A.1
Honorio, S.2
Macartney, D.P.3
-
13
-
-
0035912820
-
The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis
-
Dreijerink K, Braga E, Kuzmin I, et al. The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis. Proc Natl Acad Sci U S A 2001;98:7504-9.
-
(2001)
Proc Natl Acad Sci U S A
, vol.98
, pp. 7504-7509
-
-
Dreijerink, K.1
Braga, E.2
Kuzmin, I.3
-
14
-
-
12144289173
-
Hypermethylation of CpG islands in primary and metastatic human prostate cancer
-
Yegnasubramanian S, Kowalski J, Gonzalgo ML, et al. Hypermethylation of CpG islands in primary and metastatic human prostate cancer. Cancer Res 2004; 64:1975-86.
-
(2004)
Cancer Res
, vol.64
, pp. 1975-1986
-
-
Yegnasubramanian, S.1
Kowalski, J.2
Gonzalgo, M.L.3
-
15
-
-
0037015688
-
Frequent hypermethylation of the RASSF1A gene in prostate cancer
-
Liu L, Yoon JH, Dammann R, Pfeifer GP. Frequent hypermethylation of the RASSF1A gene in prostate cancer. Oncogene 2002;21:6835-40.
-
(2002)
Oncogene
, vol.21
, pp. 6835-6840
-
-
Liu, L.1
Yoon, J.H.2
Dammann, R.3
Pfeifer, G.P.4
-
16
-
-
16344389423
-
The tumor suppressor RASSF1A in human carcinogenesis: An update
-
Dammann R, Schagdarsurengin U, Seidel C, et al. The tumor suppressor RASSF1A in human carcinogenesis: an update. Histol Histopathol 2005;20: 645-63.
-
(2005)
Histol Histopathol
, vol.20
, pp. 645-663
-
-
Dammann, R.1
Schagdarsurengin, U.2
Seidel, C.3
-
17
-
-
20344374987
-
Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci
-
Bastian PJ, Ellinger J, Wellmann A, et al. Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci. Clin Cancer Res 2005;11:4097-106.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 4097-4106
-
-
Bastian, P.J.1
Ellinger, J.2
Wellmann, A.3
-
18
-
-
0003899323
-
-
The Japanese Urological Association and Japanese Society of Pathology, 2nd ed. Tokyo Japan, Kanahara-shuppan Co
-
The Japanese Urological Association and Japanese Society of Pathology. General rules for clinical and pathological studies on prostate cancer. 2nd ed. Tokyo (Japan): Kanahara-shuppan Co.; 1992.
-
(1992)
General rules for clinical and pathological studies on prostate cancer
-
-
-
19
-
-
0037329071
-
Transrectal colour Doppler ultrasonography for quantifying angiogenesis in prostate cancer
-
Shigeno K, Igawa M, Shiina H, Kishi H, Urakami S. Transrectal colour Doppler ultrasonography for quantifying angiogenesis in prostate cancer. BJU Int 2003; 91:223-6.
-
(2003)
BJU Int
, vol.91
, pp. 223-226
-
-
Shigeno, K.1
Igawa, M.2
Shiina, H.3
Kishi, H.4
Urakami, S.5
-
20
-
-
0030843342
-
High frequency of genetic instability of microsatellites in human prostatic adenocarcinoma
-
Dahiya R, Lee C, McCarville J, Hu W, Kaur G, Deng G. High frequency of genetic instability of microsatellites in human prostatic adenocarcinoma. Int J Cancer 1997;72:762-7.
-
(1997)
Int J Cancer
, vol.72
, pp. 762-767
-
-
Dahiya, R.1
Lee, C.2
McCarville, J.3
Hu, W.4
Kaur, G.5
Deng, G.6
-
21
-
-
0029843950
-
Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
-
Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996;93:9821-6.
-
(1996)
Proc Natl Acad Sci U S A
, vol.93
, pp. 9821-9826
-
-
Herman, J.G.1
Graff, J.R.2
Myohanen, S.3
Nelkin, B.D.4
Baylin, S.B.5
-
22
-
-
0035872408
-
High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma
-
Lo KW, Kwong J, Hui AB, et al. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Res 2001;61:3877-81.
-
(2001)
Cancer Res
, vol.61
, pp. 3877-3881
-
-
KW, L.1
Kwong, J.2
Hui, A.B.3
-
23
-
-
0141954011
-
Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer
-
Yan PS, Shi H, Rahmatpanah F, et al. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer. Cancer Res 2003;63: 6178-86.
-
(2003)
Cancer Res
, vol.63
, pp. 6178-6186
-
-
Yan, P.S.1
Shi, H.2
Rahmatpanah, F.3
-
24
-
-
18144415066
-
Chromatin inactivation precedes de novo DNA methylation during the progressive epigenetic silencing of the RASSF1A promoter
-
Strunnikova M, Schagdarsurengin U, Kehlen A, Garbe JC, Stampfer MR, Dammann R. Chromatin inactivation precedes de novo DNA methylation during the progressive epigenetic silencing of the RASSF1A promoter. Mol Cell Biol 2005;25:3923-33.
-
(2005)
Mol Cell Biol
, vol.25
, pp. 3923-3933
-
-
Strunnikova, M.1
Schagdarsurengin, U.2
Kehlen, A.3
Garbe, J.C.4
Stampfer, M.R.5
Dammann, R.6
-
25
-
-
0037115392
-
Dependence of histone modifications and gene expression on DNA hypermethylation in cancer
-
Fahrner JA, Eguchi S, Herman JG, Baylin SB. Dependence of histone modifications and gene expression on DNA hypermethylation in cancer. Cancer Res 2002;62:7213-8.
-
(2002)
Cancer Res
, vol.62
, pp. 7213-7218
-
-
Fahrner, J.A.1
Eguchi, S.2
Herman, J.G.3
Baylin, S.B.4
-
26
-
-
0032960181
-
Cancer epigenetics comes of age
-
Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet 1999;21:163-7.
-
(1999)
Nat Genet
, vol.21
, pp. 163-167
-
-
Jones, P.A.1
Laird, P.W.2
-
27
-
-
0034176798
-
DNA hypermethylation in tumorigenesis: Epigenetics joins genetics
-
Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 2000;16:168-74.
-
(2000)
Trends Genet
, vol.16
, pp. 168-174
-
-
Baylin, S.B.1
Herman, J.G.2
-
28
-
-
32844460417
-
DNA hypermethylation status of multiple genes in soft tissue sarcomas
-
Kawaguchi K, Oda Y, Saito T, et al. DNA hypermethylation status of multiple genes in soft tissue sarcomas. Mod Pathol 2006;19:106-14.
-
(2006)
Mod Pathol
, vol.19
, pp. 106-114
-
-
Kawaguchi, K.1
Oda, Y.2
Saito, T.3
-
29
-
-
0034946061
-
Methylation of the E-cadherin gene promoter correlates with progression of prostate cancer
-
Li LC, Zhao H, Nakajima K, et al. Methylation of the E-cadherin gene promoter correlates with progression of prostate cancer. J Urol 2001;166:705-9.
-
(2001)
J Urol
, vol.166
, pp. 705-709
-
-
Li, L.C.1
Zhao, H.2
Nakajima, K.3
-
30
-
-
4344633280
-
CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer
-
Enokida H, Shiina H, Igawa M, et al. CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer. Cancer Res 2004;64:5956-62.
-
(2004)
Cancer Res
, vol.64
, pp. 5956-5962
-
-
Enokida, H.1
Shiina, H.2
Igawa, M.3
-
31
-
-
22044434680
-
Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancer
-
Enokida H, Shiina H, Urakami S, et al. Ethnic group-related differences in CpG hypermethylation of the GSTP1 gene promoter among African-American, Caucasian and Asian patients with prostate cancer. Int J Cancer 2005;116:174-81.
-
(2005)
Int J Cancer
, vol.116
, pp. 174-181
-
-
Enokida, H.1
Shiina, H.2
Urakami, S.3
-
32
-
-
0842332410
-
RASSF1A, the new guardian of mitosis
-
Mathe E. RASSF1A, the new guardian of mitosis. Nat Genet 2004;36:117-8.
-
(2004)
Nat Genet
, vol.36
, pp. 117-118
-
-
Mathe, E.1
-
33
-
-
3042756223
-
Linking tumor suppression, DNA damage and the anaphase-promoting complex
-
Jackson PK. Linking tumor suppression, DNA damage and the anaphase-promoting complex. Trends Cell Biol 2004;14:331-4.
-
(2004)
Trends Cell Biol
, vol.14
, pp. 331-334
-
-
Jackson, P.K.1
-
34
-
-
0036264815
-
The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation
-
Shivakumar L, Minna J, Sakamaki T, Pestell R, White MA. The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol Cell Biol 2002;22:4309-18.
-
(2002)
Mol Cell Biol
, vol.22
, pp. 4309-4318
-
-
Shivakumar, L.1
Minna, J.2
Sakamaki, T.3
Pestell, R.4
White, M.A.5
-
35
-
-
28544442448
-
Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy
-
Rosenbaum E, Hoque MO, Cohen Y, et al. Promoter hypermethylation as an independent prognostic factor for relapse in patients with prostate cancer following radical prostatectomy. Clin Cancer Res 2005;11: 8321-5.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 8321-8325
-
-
Rosenbaum, E.1
Hoque, M.O.2
Cohen, Y.3
-
36
-
-
0036274359
-
The fundamental role of epigenetic events in cancer
-
Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002;3: 415-28.
-
(2002)
Nat Rev Genet
, vol.3
, pp. 415-428
-
-
Jones, P.A.1
Baylin, S.B.2
-
37
-
-
0032948005
-
Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer
-
Cameron EE, Bachman KE, Myohanen S, Herman JG, Baylin SB. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 1999;21:103-7.
-
(1999)
Nat Genet
, vol.21
, pp. 103-107
-
-
Cameron, E.E.1
Bachman, K.E.2
Myohanen, S.3
Herman, J.G.4
Baylin, S.B.5
|